| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |